MELANOMAS, FROM THE CELL-CYCLE POINT-OF-VIEW (REVIEW)

Citation
R. Halaban et al., MELANOMAS, FROM THE CELL-CYCLE POINT-OF-VIEW (REVIEW), INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(2), 1998, pp. 419-425
Citations number
86
Categorie Soggetti
Medicine, Research & Experimental
ISSN journal
11073756
Volume
1
Issue
2
Year of publication
1998
Pages
419 - 425
Database
ISI
SICI code
1107-3756(1998)1:2<419:MFTCP(>2.0.ZU;2-B
Abstract
Transformation of melanocytes to metastatic melanoma cells is characte rized by unrestricted proliferation under growth-factor-deprived condi tions, genetic loss of cyclin dependent kinase (CDK) inhibitors (CKI, e.g. p16(INK4A)), and aberrant production of autocrine growth factors (e.g. basic fibroblast growth factor). The latter induces increased ex pression of positive CDK regulators (e.g. cyclin D1) and reduced expre ssion of additional CKIs (e.g. p27(KIP1)). Combined, these events lead to sustained CDK activity and hyperphosphorylation/inactivation of th e retinoblastoma tumor suppressor protein (Rb). The persistent Rb phos phorylation causes the accumulation of E2F and the transcription of it s target genes whose products promote cell cycle progression.